Austria Country Drug Report 2019

Drug-related infectious diseases

In Austria, the prevalence of infectious diseases among people who inject drugs (PWID) is based on results from diagnostic tests carried out in treatment facilities and low-threshold centres. Information on the prevalence of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) among drug-related deaths is routinely collected, but is not provided in all autopsy reports.

Prevalence of HIV and HCV antibodies among people who inject drugs in Austria (%)
  Region HCV HIV
Data from 2017.
National 34 8.30
Sub-national 60.0 - 83.5 0.0 - 0.0

Although based on a small sample size and not representative of all PWID, sub-national data based on serological tests indicate that HCV infection is the most prevalent drug-related infectious disease among PWID in Austria, while HIV infection remains at low levels, and prevalence of hepatitis B virus infection has remained stable for several years. Data from the Austrian HIV cohort indicate that numbers of newly registered HIV-positive individuals among PWID have decreased in recent years.


Austria main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.